Risk Evaluation And Mitigation Strategy (REMS)
Showing 1-1 of 1 results
Pharmacists and mifepristone
Answers for pharmacists (and other providers) about the current status of mifepristone.
Oct 20, 2023
Join Bedsider Providers+
Stay on top of SRH policy, mis/disinformation, clinical information and research - all in one place. Members help sustain tools young people rely on, including Bedsider.
Starting at $8/month. Cancel anytime.